# Perspective Therapeutics, Inc.: filings

CATX · NYSE · CIK 728387 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/catx.md) · [Financials](/companies/catx/financials.md) · [Filings](/companies/catx/filings.md) · [Insiders](/companies/catx/insiders.md)

## Reports and events: 400 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 291, 4 236, 10-Q 53, 424B5 39, CT ORDER 27, 3 22, DEF 14A 19, DEFA14A 18, 10-K 17, 4/A 12, SD 12, EFFECT 11, SC 13G 11, 8-K/A 10, SC 13G/A 10, S-3 9, S-8 9, SCHEDULE 13G/A 8, UPLOAD 8, CORRESP 7, SCHEDULE 13G 7, PRE 14A 5, D 4, S-3/A 4, 10-K/A 2, 10-Q/A 2, 424B3 2, FWP 2, POS AM 2, S-3MEF 2, S-8 POS 2, SCHEDULE 13D/A 2, 10-KT 1, 144 1, DEFM14A 1, POSASR 1, POS EX 1, PREM14A 1, S-1 1, S-1/A 1, S-3ASR 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 10:52 ET | [8-K](/filings/0001193125-26-429770.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429770 |
| 2026-10-08 | 10:28 ET | [8-K](/filings/0001193125-26-417384.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417384 |
| 2026-10-01 | 20:08 ET | [8-K](/filings/0001193125-26-410663.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-410663 |
| 2026-09-23 | 16:19 ET | [SCHEDULE 13D/A](/filings/0001193125-26-399446.md) | Ownership report, active investor, amended | 0001193125-26-399446 |
| 2026-09-14 | 10:20 ET | [8-K](/filings/0001193125-26-389785.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389785 |
| 2026-09-08 | 21:16 ET | [8-K](/filings/0001193125-26-385362.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-385362 |
| 2026-09-04 | 16:48 ET | [SCHEDULE 13D/A](/filings/0001193125-26-383775.md) | Ownership report, active investor, amended | 0001193125-26-383775 |
| 2026-08-10 | 20:34 ET | [10-Q](/filings/0001193125-26-342512.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342512 |
| 2026-08-10 | 20:30 ET | [8-K](/filings/0001193125-26-342495.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342495 |
| 2026-08-03 | 20:15 ET | [8-K](/filings/0001193125-26-330599.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-330599 |
| 2026-07-01 | 20:10 ET | [8-K](/filings/0001193125-26-292547.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-292547 |
| 2026-06-01 | 10:30 ET | [8-K](/filings/0001193125-26-249594.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-249594 |
| 2026-05-27 | 20:20 ET | [8-K](/filings/0001193125-26-241940.md) | 5.07 Shareholder vote results | 0001193125-26-241940 |
| 2026-05-22 | 22:02 ET | [8-K](/filings/0001193125-26-234991.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234991 |
| 2026-05-11 | 20:13 ET | [10-Q](/filings/0001193125-26-216790.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216790 |
| 2026-05-11 | 20:10 ET | [8-K](/filings/0001193125-26-216777.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216777 |
| 2026-05-04 | 20:43 ET | [8-K](/filings/0001193125-26-204161.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-204161 |
| 2026-04-20 | 10:05 ET | [8-K](/filings/0001193125-26-162578.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-162578 |
| 2026-04-16 | 20:10 ET | [DEF 14A](/filings/0001193125-26-159005.md) | Proxy statement, period 2026-04-15 | 0001193125-26-159005 |
| 2026-04-01 | 20:16 ET | [8-K](/filings/0001193125-26-137930.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-137930 |
| 2026-03-16 | 20:12 ET | [10-K](/filings/0000728387-26-000004.md) | Annual report, period 2025-12-31 | 0000728387-26-000004 |
| 2026-03-16 | 20:10 ET | [8-K](/filings/0000728387-26-000003.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000728387-26-000003 |
| 2026-02-03 | 21:07 ET | [8-K](/filings/0001193125-26-035508.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-035508 |
| 2026-02-02 | 12:44 ET | [8-K](/filings/0001193125-26-032706.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-032706 |
| 2026-01-14 | 12:00 ET | [8-K](/filings/0001193125-26-012259.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-012259 |
| 2026-01-12 | 13:20 ET | [8-K](/filings/0001193125-26-009846.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009846 |
| 2026-01-09 | 12:25 ET | [8-K](/filings/0001193125-26-008277.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-008277 |
| 2025-12-01 | 21:13 ET | [8-K](/filings/0001193125-25-303895.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-303895 |
| 2025-11-10 | 21:23 ET | [10-Q](/filings/0001193125-25-274328.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274328 |
| 2025-11-10 | 21:20 ET | [8-K](/filings/0001193125-25-274318.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-274318 |
| 2025-11-06 | 13:00 ET | [8-K](/filings/0001193125-25-268124.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-268124 |
| 2025-11-03 | 21:30 ET | [8-K](/filings/0001193125-25-262636.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-262636 |
| 2025-10-20 | 10:02 ET | [8-K](/filings/0001193125-25-242912.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242912 |
| 2025-10-01 | 11:15 ET | [8-K](/filings/0001193125-25-225858.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-225858 |
| 2025-09-04 | 11:04 ET | [8-K](/filings/0000728387-25-000013.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000728387-25-000013 |
| 2025-09-03 | 11:04 ET | [8-K](/filings/0000728387-25-000010.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000728387-25-000010 |
| 2025-09-02 | 11:00 ET | [8-K](/filings/0000728387-25-000006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000728387-25-000006 |
| 2025-08-13 | 11:05 ET | [10-Q](/filings/0000950170-25-107619.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107619 |
| 2025-08-13 | 10:45 ET | [8-K](/filings/0000950170-25-107609.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-107609 |
| 2025-08-01 | 20:07 ET | [8-K](/filings/0000950170-25-101414.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-101414 |
| 2025-07-03 | 12:02 ET | [8-K](/filings/0000950170-25-093556.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-093556 |
| 2025-06-23 | 10:32 ET | [8-K](/filings/0000950170-25-088700.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088700 |
| 2025-06-03 | 12:05 ET | [8-K](/filings/0000950170-25-080568.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-080568 |
| 2025-05-30 | 21:23 ET | [8-K](/filings/0000950170-25-079876.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-079876 |
| 2025-05-28 | 21:23 ET | [8-K](/filings/0000950170-25-078439.md) | 5.07 Shareholder vote results | 0000950170-25-078439 |
| 2025-05-12 | 20:34 ET | [10-Q](/filings/0000950170-25-069314.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069314 |
| 2025-05-12 | 20:30 ET | [8-K](/filings/0000950170-25-069301.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-069301 |
| 2025-05-01 | 21:05 ET | [8-K](/filings/0000950170-25-061994.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-061994 |
| 2025-04-29 | 11:10 ET | [8-K](/filings/0000950170-25-059557.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-059557 |
| 2025-04-16 | 20:30 ET | [DEF 14A](/filings/0000950170-25-054776.md) | Proxy statement, period 2024-12-31 | 0000950170-25-054776 |

Page 1 of 8. [Older](/companies/catx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. No prices; not investment advice.